Picture of Resverlogix logo

RVX — Resverlogix News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Resverlogix Corp entered into a Right of First Refusal Agreement with Hepalink USA Inc

Oct 24 (Reuters) - Resverlogix Corp  RVX.TO  
    * Resverlogix Corp -  entered into a Right of First Refusal 
Agreement with Hepalink USA Inc 
    * Resverlogix Corp - Hepalink USA paid $8 million to 
Resverlogix in consideration for right of first refusal granted 
    * Resverlogix - during first 60 day period, deal may only 
be terminated upon mutual agreement; thereafter, agreement may 
be terminated by either party 
    * Resverlogix-Hepalink USA granted Right of First Refusal in 
connection with licensing of right to develop, among others, 
products having RVX-208 in U.S. 
    * Resverlogix-Hepalink USA granted Right of First Refusal 
related to licensing of right to develop products with RVX-208 
in U.S. until April 15, 2019 
 
Source text for Eikon:  ID:nGNXOGGTUa  
Further company coverage:  RVX.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;;))

Recent news on Resverlogix

See all news